What is Prime Medicine's net investment in lease?

Prime Medicine (PRME) reported net investment in lease of $123.33M in Q1 2026.

How has Prime Medicine's net investment in lease changed year-over-year?

Prime Medicine's net investment in lease decreased by 1.6% year-over-year, from $125.38M to $123.33M.

What is the long-term trend for Prime Medicine's net investment in lease?

Over 5 years (2020 to 2025), Prime Medicine's net investment in lease has grown at a 114.2% compound annual growth rate (CAGR), from $2.8M to $126.18M.

Prime Medicine PRME Net Investment in Lease

Net Investment in Lease at other companies

Vertex PharmaceuticalsVRTX

——

Intellia TherapeuticsNTLA

——

CRISPR TherapeuticsCRSP

——

Beam TherapeuticsBEAM

——

RegenxbioRGNX

——

Sarepta Therapeutics, Inc.SRPT

——

Other financials

Income statement

See full

Revenue$838.0K-61.6%

Operating income-$50.7M+3.3%

Net income-$49.1M+5.3%

EPS (diluted)-$0.28+30.0%

Balance sheet

See full

Cash & equivalents$77.8M-26.6%

Total debt$114.5M-5.5%

Total equity$76.7M-28.3%

Total assets$294.7M-10.2%

Cash flow

See full

Operating cash flow-$42.7M+12.6%

CapEx$214.0K-91.2%

Free cash flow-$42.9M+16.3%

Valuation

See full

Market cap$574.36M+111%

Enterprise value$611.08M+113%

P/S124×+6.3×

Profitability

See full

Operating margin-4,498.1%-1,134pp

Net margin-4,342.4%-1,099pp

FCF margin-3,607.4%—

Returns & leverage

See full

Return on equity-216.1%+1,519pp

Debt / equity1.5×+0.4×

Current ratio3.8×-1.0×

Where this comes from

Reported directly by Prime Medicine in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Prime Medicine's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Prime Medicine's net investment in lease?: Prime Medicine (PRME) reported net investment in lease of $123.33M in Q1 2026.
How has Prime Medicine's net investment in lease changed year-over-year?: Prime Medicine's net investment in lease decreased by 1.6% year-over-year, from $125.38M to $123.33M.
What is the long-term trend for Prime Medicine's net investment in lease?: Over 5 years (2020 to 2025), Prime Medicine's net investment in lease has grown at a 114.2% compound annual growth rate (CAGR), from $2.8M to $126.18M.